InMed Pharmaceuticals Inc. (INM:NASDAQ) closed at $1.44 on October 23, 2026, up 8.27% on the day. The stock trades 38.2% below its 52-week high of $2.33 and 150.4% above its 52-week low of $0.575. Over the past year, it lost 30.4%. InMed Pharmaceuticals Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, INM closed higher on 94 days (37%). Its best day was May 19, 2026 (+134.95%) and its worst was December 15, 2025 (-16.08%). The stock moved 10% or more in a single session 12 times. It opened at least 5% above the previous day's high 4 times.
InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based therapies combined with drug delivery systems. It is focused on the treatment of diseases including pain and inflammation, dermatology, Orofacial Pain, Glaucoma, ocular, CNS, respiratory, metabolic diseases, and others.
Find more stocks like INM with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.